Hanmi Pharm shares jump 30% on Genentech obesity drug deal
Hanmi Pharm shares jump 30% on Genentech obesity drug deal
Similar Posts
Nagaland Sambad Lottery Result Today, 2-8-2026 LIVE: Dear 1PM WISH, 6PM Dear EMPIRE & 8PM Dear MAGIC Sunday Weekly Lucky Draw Winning Numbers List for Rs 1 Crore Prize Money
Personal Finance Updated: Sunday, August 2, 2026, 13:25 [IST] The Nagaland State Lottery Department has announced the results of the 1 PM Dear WISH Sunday Weekly Lottery, kicking off Sunday’s triple-draw schedule. With the first draw now complete, lottery enthusiasts are awaiting the remaining Dear Empire Sunday draw at 6 PM and the Dear Magic…
As gold retreats, should advisors reconsider how they access it?
Can gold still hedge risk at current prices? In Dragosits view, those four drivers are a wider erosion of trust in institutions and central banks, the ongoing de-dollarization and gold stockpiling by non-Western central banks, ongoing geopolitical uncertainty, and high levels of fiscal debt in the developed world. Put simply, as people lose trust in…
5 career truths nobody tells you
Below, Emily Durham shares five key insights from her new book, Clock In: No-BS Advice for Getting Ahead in Your Career (Without Losing Your Mind). Emily, also known as Emily the Recruiter on social media, is a recruiter-turned career-coach with an audience of over 3 million people across Instagram, TikTok, YouTube, and her podcast. What’s the…
Harworth Rejects Peel Holdings’ $787M Takeover Bid on Valuation Basis
Editorial & Advertiser disclosure Global Banking & Finance Review® is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press…
Results of the June 2026 survey on credit terms and conditions in euro-denominated securities financing and OTC derivatives markets (SESFOD)
24 July 2026 Overall, respondents reported slight net easing of credit terms and conditions for all counterparty types for second consecutive quarter Dealers repriced across all collateral types, in particular equity, as demand for secured funding increased Non-price credit terms remained broadly unchanged across counterparty types, secured financing transactions and non-centrally cleared OTC derivatives markets…
